Nuclear medicine techniques for selective internal radiotherapy of liver cancer

Peter Frøhlich Staanum; Anne Kirstine Arveschoug; Stine Maria Jentoft Kramer; Jens Erik Nielsen; Dennis Tønner Nielsen; Peter Ott; Henning Grønbæk; Gerda Elisabeth Villadsen

Nuclear medicine techniques for selective internal radiotherapy of liver cancer

Peter Frøhlich Staanum, Anne Kirstine Arveschoug, Stine Maria Jentoft Kramer, Jens Erik Nielsen, Dennis Tønner Nielsen, Peter Ott, Henning Grønbæk, Gerda Elisabeth Villadsen

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

Abstract

Selective internal radiation therapy (SIRT) of hepatocellular carcinoma has been introduced at Aarhus University Hospital. 90Y-microspheres are implanted in the tumour by catheterization of the tumour feeding liver artery. Pretreatment angiography and test treatment using 99mTc-labelled particles followed by scintigraphy ensure a feasible and effective treatment. Post-treatment imaging of radiation from 90Y visualize the localization of microspheres. Currently, SIRT is also applied for liver metastases of neuroendocrine tumours. Future indications may include other liver tumours and metastases.

Original language	English
Journal	Ugeskrift for Læger
Volume	179
Issue	1
ISSN	0041-5782
Publication status	Published - 2 Jan 2017

Cite this

@article{29f9aa5ab1674d9998b51a04b1c88ab0,

title = "Nuclear medicine techniques for selective internal radiotherapy of liver cancer",

abstract = "Selective internal radiation therapy (SIRT) of hepatocellular carcinoma has been introduced at Aarhus University Hospital. 90Y-microspheres are implanted in the tumour by catheterization of the tumour feeding liver artery. Pretreatment angiography and test treatment using 99mTc-labelled particles followed by scintigraphy ensure a feasible and effective treatment. Post-treatment imaging of radiation from 90Y visualize the localization of microspheres. Currently, SIRT is also applied for liver metastases of neuroendocrine tumours. Future indications may include other liver tumours and metastases.",

author = "Staanum, {Peter Fr{\o}hlich} and Arveschoug, {Anne Kirstine} and Kramer, {Stine Maria Jentoft} and Nielsen, {Jens Erik} and Nielsen, {Dennis T{\o}nner} and Peter Ott and Henning Gr{\o}nb{\ae}k and Villadsen, {Gerda Elisabeth}",

year = "2017",

month = jan,

day = "2",

language = "English",

volume = "179",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Den Almindelige Danske L{\ae}geforening",

number = "1",

}

TY - JOUR

T1 - Nuclear medicine techniques for selective internal radiotherapy of liver cancer

AU - Staanum, Peter Frøhlich

AU - Arveschoug, Anne Kirstine

AU - Kramer, Stine Maria Jentoft

AU - Nielsen, Jens Erik

AU - Nielsen, Dennis Tønner

AU - Ott, Peter

AU - Grønbæk, Henning

AU - Villadsen, Gerda Elisabeth

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Selective internal radiation therapy (SIRT) of hepatocellular carcinoma has been introduced at Aarhus University Hospital. 90Y-microspheres are implanted in the tumour by catheterization of the tumour feeding liver artery. Pretreatment angiography and test treatment using 99mTc-labelled particles followed by scintigraphy ensure a feasible and effective treatment. Post-treatment imaging of radiation from 90Y visualize the localization of microspheres. Currently, SIRT is also applied for liver metastases of neuroendocrine tumours. Future indications may include other liver tumours and metastases.

AB - Selective internal radiation therapy (SIRT) of hepatocellular carcinoma has been introduced at Aarhus University Hospital. 90Y-microspheres are implanted in the tumour by catheterization of the tumour feeding liver artery. Pretreatment angiography and test treatment using 99mTc-labelled particles followed by scintigraphy ensure a feasible and effective treatment. Post-treatment imaging of radiation from 90Y visualize the localization of microspheres. Currently, SIRT is also applied for liver metastases of neuroendocrine tumours. Future indications may include other liver tumours and metastases.

UR - http://www.scopus.com/inward/record.url?scp=85060281377&partnerID=8YFLogxK

M3 - Review

C2 - 28074772

AN - SCOPUS:85060281377

SN - 0041-5782

VL - 179

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 1

ER -

Nuclear medicine techniques for selective internal radiotherapy of liver cancer

Abstract

Other files and links

Fingerprint

Cite this